NGNE icon

Neurogene

81 hedge funds and large institutions have $49.7M invested in Neurogene in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

4% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 26

58% less capital invested

Capital invested by funds: $119M → $49.7M (-$69M)

Holders
81
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$337K
Puts
$246K
Net Calls
Net Calls Change

Top Buyers

1 +$861K
2 +$800K
3 +$764K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$403K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$205K

Top Sellers

1 -$4.15M
2 -$1.08M
3 -$601K
4
OM
Opaleye Management
Massachusetts
-$484K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$278K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.18M
2
$6.51M
3
$4.84M
4
$4.81M
5
$3.39M
6
$2.41M
7
$2.39M
8
$2.32M
9
$2.3M
10
$1.49M
11
$1.47M
12
$1.27M
13
$1.1M
14
$1.1M
15
$861K
16
$581K
17
$543K
18
$459K
19
$399K
20
$374K
21
$324K
22
$273K
23
$264K
24
$252K
25
$240K